You need JavaScript to view this

Demonstration of specific dopamine receptors on human pituitary adenomas

Abstract

Dopamine receptors on human pituitary adenoma membranes were characterized using (/sup 3/H)spiperone as the radioligand. The specific (/sup 3/H)spiperone binding sites on prolactin (PRL)-secreting adenoma membranes were recognized as a dopamine receptor, based upon the data showing high affinity binding, saturability, specificity, temperature dependence, and reversibility. All of 14 PRL-secreting adenomas had high affinity dopamine receptors, with a dissociation constant (Kd) of 0.85 +- 0.11 nmol/l (mean+-SEM) and a maximal binding capacity (Bmax) of 428 +- 48.6 fmol/mg protein. Among 14 growth hormone (GH)-secreting adenomas examined, 8 (57%) had dopamine receptors with a Kd of 1.90 +- 0.47 nmol/l and a Bmax of 131 +- 36.9 fmol/mg protein. Furthermore, 15 of 24 (58%) nonsecreting pituitary adenomas also had dopamine receptors with a Kd of 1.86 +- 0.37 nmol/l and a Bmax of 162 +- 26.0 fmol/mg protein. These results indicate that some GH-secreting adenomas as well as some nonsecreting pituitary adenomas contain dopamine receptors. But their affinity and number of binding sites are significantly lower (P<0.05) and fewer (P<0.001) respectively, than those in PRL-secreting adenomas.
Publication Date:
Jan 01, 1987
Product Type:
Journal Article
Reference Number:
NORN-87-000037; EDB-87-098012
Resource Relation:
Journal Name: Acta Endocrinol.; (Denmark); Journal Volume: 114
Subject:
59 BASIC BIOLOGICAL SCIENCES; DOPAMINE; RECEPTORS; PITUITARY GLAND; ADENOMAS; MAN; SPECIFICITY; SPIPERONE; TRACER TECHNIQUES; TRITIUM COMPOUNDS; AMINES; ANIMALS; AROMATICS; AUTONOMIC NERVOUS SYSTEM AGENTS; BODY; CARDIOTONICS; CARDIOVASCULAR AGENTS; DISEASES; DRUGS; ENDOCRINE GLANDS; GLANDS; HYDROXY COMPOUNDS; ISOTOPE APPLICATIONS; LABELLED COMPOUNDS; MAMMALS; MEMBRANE PROTEINS; NEOPLASMS; NEUROREGULATORS; ORGANIC COMPOUNDS; ORGANS; PHENOLS; POLYPHENOLS; PRIMATES; PROTEINS; SYMPATHOMIMETICS; VERTEBRATES; 550201* - Biochemistry- Tracer Techniques; 550901 - Pathology- Tracer Techniques
OSTI ID:
6619761
Research Organizations:
Third Department of Internal Medicine, Osaka University Hospital, Osaka JA; Department of Neurosurgery, Osaka Centre for Adult Disease, Osaka JA; Department of Neurosurgery, Hiroshima University Hospital, Hiroshima JA
Country of Origin:
Denmark
Language:
English
Other Identifying Numbers:
Journal ID: CODEN: ACENA
Submitting Site:
NWN
Size:
Pages: 595-602
Announcement Date:
Jun 01, 1987

Citation Formats

Koga, Masafumi, Nakao, Haruyoshi, Arao, Masayo, Sato, Bunzo, Noma, Keizo, Morimoto, Yasuhiko, Kishimoto, Susumu, Mori, Shintaro, and Uozumi, Toru. Demonstration of specific dopamine receptors on human pituitary adenomas. Denmark: N. p., 1987. Web.
Koga, Masafumi, Nakao, Haruyoshi, Arao, Masayo, Sato, Bunzo, Noma, Keizo, Morimoto, Yasuhiko, Kishimoto, Susumu, Mori, Shintaro, &amp; Uozumi, Toru. Demonstration of specific dopamine receptors on human pituitary adenomas. Denmark.
Koga, Masafumi, Nakao, Haruyoshi, Arao, Masayo, Sato, Bunzo, Noma, Keizo, Morimoto, Yasuhiko, Kishimoto, Susumu, Mori, Shintaro, and Uozumi, Toru. 1987. "Demonstration of specific dopamine receptors on human pituitary adenomas." Denmark.
@misc{etde_6619761,
title = {Demonstration of specific dopamine receptors on human pituitary adenomas}
author = {Koga, Masafumi, Nakao, Haruyoshi, Arao, Masayo, Sato, Bunzo, Noma, Keizo, Morimoto, Yasuhiko, Kishimoto, Susumu, Mori, Shintaro, and Uozumi, Toru}
abstractNote = {Dopamine receptors on human pituitary adenoma membranes were characterized using (/sup 3/H)spiperone as the radioligand. The specific (/sup 3/H)spiperone binding sites on prolactin (PRL)-secreting adenoma membranes were recognized as a dopamine receptor, based upon the data showing high affinity binding, saturability, specificity, temperature dependence, and reversibility. All of 14 PRL-secreting adenomas had high affinity dopamine receptors, with a dissociation constant (Kd) of 0.85 +- 0.11 nmol/l (mean+-SEM) and a maximal binding capacity (Bmax) of 428 +- 48.6 fmol/mg protein. Among 14 growth hormone (GH)-secreting adenomas examined, 8 (57%) had dopamine receptors with a Kd of 1.90 +- 0.47 nmol/l and a Bmax of 131 +- 36.9 fmol/mg protein. Furthermore, 15 of 24 (58%) nonsecreting pituitary adenomas also had dopamine receptors with a Kd of 1.86 +- 0.37 nmol/l and a Bmax of 162 +- 26.0 fmol/mg protein. These results indicate that some GH-secreting adenomas as well as some nonsecreting pituitary adenomas contain dopamine receptors. But their affinity and number of binding sites are significantly lower (P<0.05) and fewer (P<0.001) respectively, than those in PRL-secreting adenomas.}
journal = []
volume = {114}
journal type = {AC}
place = {Denmark}
year = {1987}
month = {Jan}
}